Therefore, polymorphisms in UGT1A genes may ultimately lead to various metabolic changes in patients with NAFLD and large-scale OMICS analysis might be necessary to get a full picture of the transcriptomic and proteomic alterations associated with this common UGT1A-SNP genotype. The gene discussed is UGT1A1; the disease is metabolic dysfunction-associated steatotic liver disease.